Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Event Details


Biosimilars and Biobetters 2017

Biosimilars and Biobetters 2017 returns to London this autumn for its 8th annual show to provide the latest updates on regulation, strategies for market access and commercial success.

Add this event to your calendar: iCal   Google Calendar


SMi Group present the 2017 8th annual event on Biosimilars & Biobetters, taking place on 27-28 Sept in London, UK.

As the patents for several innovator biologics expire, biopharmaceutical companies are taking the opportunity to develop more affordable forms creating a rapidly booming biosimilars market. However, as the field of biosimilars evolves, challenges in immunogenicity studies, securing market share, exclusivity and regulations still persist.

Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and critical updates on interchangeability guidelines and patient litigation.


Bernd Liedert, Snr Clinical Program Leader Biosimilars, Boehringer Ingelheim
Ho-Ung Kim, Division Head Strategy & Operations, Celltrion Healthcare
Sarah Rickwood, VP, Head of European Thought Leadership, QuintilesIMS
Matthew Turner, Global Medical Dir, Biosimilars, Merck Group
Steiner Madsen, Medical Dir, Norwegian Medicines Agency
Thomas Sachnik, Snr Manager Strategic Associate to the President & CEO Generics Europe, Teva
Harish Pai, Principal Scientific Manager, Biocon
Ildiko Aradi, Head Clinical Development of Biologics, Gedeon Richter
Glenn Kazo, President & COO, Prolong Pharmaceuticals


• Increase speed of entry and compliance through informed guidance on interchangeability, patient litigation and IP laws
• Develop strategies for market access and expansion by identifying future projections
• Evolve clinical developments through insight into orphan drugs, in-vitro functional assays and data extrapolation
• Create a competitive edge through an understanding on switching studies
• Hear case studies on required testing such as immunogenicity and bio-similarity tests
• Discuss solutions in exclusivity and HCP acceptance
• Unique coverage of biobetters from experts in the field


Conference + 2 Workshops: GBP 2697, Conference +1 Workshop: GBP 2098, Conference Only: GBP 1499


Teri Arri

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.